Recently, the identification of single-nucleotide polymorphisms (SNPs) in human IPMK from immune-mediated diseases (e.g., rheumatoid arthritis, psoriasis, and Crohn’s disease) suggests that IPMK contributes to the onset and progression of these diseases [51]. Here, IPMK is linked to psoriasis.